| Literature DB >> 3612689 |
L M Nguyen, E Niesor, C L Bentzen.
Abstract
New diphosphonate compounds and related derivatives were synthesized and investigated for their activity in specifically inducing plasma high density lipoproteins (HDL) and high density lipoprotein cholesterol (HDL-C) in normal rats. The screening of numerous compounds has permitted the determination of the structural variations leading to optimal plasma lipid altering activity, indicating antiatherosclerotic potential. Among the compounds observed to be the most active, dimethyl alpha-(dimethoxyphosphinyl)-p-chlorobenzyl phosphate (20, SR-202, mifobate) was selected for further pharmacological and subsequent clinical development.Entities:
Mesh:
Substances:
Year: 1987 PMID: 3612689 DOI: 10.1021/jm00391a027
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446